Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) 2018
Specialty Drug Pipeline Review Focuses on Competition, Cancer Drugs
April 24, 2018
Dr Robert Navarro Discusses Progress in Shift to Value-Based Care
April 24, 2018
Currently Reading
Brian Litten Outlines How Medication Therapy Management Can Address Opioid Misuse
April 24, 2018
Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration
April 25, 2018
Dr Aimee Tharaldson Discusses Key Market Trends in Specialty Pharmacy
April 25, 2018
Migraines in the US Are More Than Just a Pain Problem
April 25, 2018
Market Access Teams Face New Challenges in Pharma
April 25, 2018
Cardiologist Talks About Value of Monoclonal Antibody Evolocumab
April 26, 2018
Dr Somali Burgess on the Role of Patient-Reported Outcomes in Managed Care Pharmacy
April 26, 2018
Dr Tina Joseph Discusses Collaborative Practice Agreements Between Pharmacists, Physicians
April 26, 2018
Navigating the Rocky Waters to Value-Based Healthcare
April 26, 2018
Hemophilia: Treatment Landscape, Costs, and Disease Management
April 26, 2018
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 05, 2018
Dr Calvin Knowlton Outlines Benefits Seen From Enhanced Medication Therapy Management
May 06, 2018
The Rise of Orphan Drugs for Rare Diseases
May 07, 2018
Dr Robert Navarro Foresees Unintended Consequences From Shift to Value-Based Care
May 12, 2018
Dr Kimberly Lenz: Identifying Patients Most at Risk For Substance Abuse
May 13, 2018
Brian Litten Outlines Challenges With Adopting Medication Therapy Management Services
May 17, 2018
Dr Tina Joseph Outlines Pharmacists' Role in Managing Chronic Diseases, Value-Based Care Models
May 19, 2018
Dr Calvin Knowlton on Innovative Practices in Enhanced Medication Therapy Management
May 20, 2018
Dr Ashley Pappas Discusses Collaboration Between Academic Centers and Payers
May 24, 2018
Dr Robert Navarro on Pharma Implementing Value, Best Practices for Value-Based Contracts
May 25, 2018
Drug Approvals That Dr Aimee Tharaldson Is Keeping an Eye on for 2019
May 27, 2018
Dr Kimberly Lenz on Implementing, Enforcing Appropriate Opioid Prescribing
June 04, 2018

Brian Litten Outlines How Medication Therapy Management Can Address Opioid Misuse

Through Medication Therapy Management, a pharmacist will be able to recognize indications of potential opioid abuse, explained Brian Litten, JD, chief strategic officer, Tabula Rasa HealthCare.


Through Medication Therapy Management, a pharmacist will be able to recognize indications of potential opioid abuse, explained Brian Litten, JD, chief strategic officer, Tabula Rasa HealthCare.

Transcript

How can Medication Therapy Management be used to address opioid misuse?

In the course of an MTM [Medication Therapy Management] consultation or a comprehensive medication review, a pharmacist will review all of the medications the patient is taking, and that will also include, in better MTM programs, over-the-counter medications and vitamin supplements. In the course of looking at all of the medications, which will include opioids, a pharmacist will be able to see trends, with respect to the opioids, such as multiple refills, different prescribers writing prescriptions for opioids, and filling prescriptions across state lines. These are all indications of potential abuse.

Tabula Rasa HealthCare has announced their Optimized Opioid Solution. How will this solution identify and prevent opioid misuse?

TRHC looks at medications in the MTM context very differently than other MTM companies. Rather than looking at single drug to drug interactions, Tabula Rasa looks at accumulative, simultaneous multi-drug interactions. So, we’re looking at the entire cocktail of medications. What this means with respect to opioids is that a patient who’s taking opioids and other medications, there may be interactions between those other medications and the opioid that can lead to serious problems.

The opioid could provide more analgesic impact to the body than the prescriber would expect, or it might provide less, which also causes serious problems. So, by identifying the impact of the other medications that a patient is taking along with the opioid, we can get a head start on risk associated with unintentional misuse of opioids that lead to potential abuse.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up